Neil Bertelsen
Biographic Data
| ID | 2316440 |
|---|---|
| NAME | Neil Bertelsen |
| GIVEN NAMES | Neil |
| FAMILY NAME | Bertelsen |
| SIGNATURE | BERTELSEN N |
| AFFILIATIONS | Patient & Citizen Involvement in HTA Group HTAi |
| ORCID | 0000-0003-3235-5810 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 4 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2018 |
| LATEST PUBLICATION YEAR | 2021 |
| H-INDEX | 0 |
The Role of Patient Experience in the Value Assessment of Complex Technologies – Do HTA Bodies Need to Reconsider How Value is Assessed
The value of patient experience is becoming increasingly recognized by healthcare stakeholders. • Integration of patient experience in health technology assessment is not universally adopted. • This is challenging when assessing complex health technologies and holistic solutions. • New value frameworks can formalize the patient perspective into complex technology assessments. • This paper searched for and summarized current patient experience val…
Understanding multi‐stakeholder needs, preferences and expectations to define effective practices and processes of patient engagement in medicine development
BACKGROUND: The holistic evolution of patient engagement in medicines development requires a more detailed understanding of the needs of all involved stakeholders, and one that better accounts for the specific needs of some potentially vulnerable patient populations and key stages in medicines development. OBJECTIVE: The purpose of this convergent mixed-methods study was to better understand the needs of different stakeholders concerning patient …
Valuing patient engagement
Much attention in health technology assessment (HTA), a health system governance mechanism used for determining the value of health technologies, is being paid to improving the quality and patient-relevance of the evidence used in assessment pratices. Whilst the direct involvement of patient actors throughout HTA processes has become a more routine element of institutional practice, the 'impacts' of patient engagement (PE) initiatives have proven…
What do stakeholders expect from patient engagement
BACKGROUND: Meaningful patient engagement (PE) in medicines development and during the life cycle of a product requires all stakeholders have a clear understanding of respective expectations. OBJECTIVE: A qualitative survey was undertaken to understand stakeholder expectations. DESIGN: The survey explored 4 themes from the perspective of each stakeholder group: meaning, views, expectations and priorities for PE. Participants were grouped into 7 c…
No prominent works on this page.
What do stakeholders expect from patient engagement
BACKGROUND: Meaningful patient engagement (PE) in medicines development and during the life cycle of a product requires all stakeholders have a clear understanding of respective expectations. OBJECTIVE: A qualitative survey was undertaken to understand stakeholder expectations. DESIGN: The survey explored 4 themes from the perspective of each stakeholder group: meaning, views, expectations and priorities for PE. Participants were grouped into 7 c…
The Role of Patient Experience in the Value Assessment of Complex Technologies – Do HTA Bodies Need to Reconsider How Value is Assessed
The value of patient experience is becoming increasingly recognized by healthcare stakeholders. • Integration of patient experience in health technology assessment is not universally adopted. • This is challenging when assessing complex health technologies and holistic solutions. • New value frameworks can formalize the patient perspective into complex technology assessments. • This paper searched for and summarized current patient experience val…
Understanding multi‐stakeholder needs, preferences and expectations to define effective practices and processes of patient engagement in medicine development
BACKGROUND: The holistic evolution of patient engagement in medicines development requires a more detailed understanding of the needs of all involved stakeholders, and one that better accounts for the specific needs of some potentially vulnerable patient populations and key stages in medicines development. OBJECTIVE: The purpose of this convergent mixed-methods study was to better understand the needs of different stakeholders concerning patient …
Valuing patient engagement
Much attention in health technology assessment (HTA), a health system governance mechanism used for determining the value of health technologies, is being paid to improving the quality and patient-relevance of the evidence used in assessment pratices. Whilst the direct involvement of patient actors throughout HTA processes has become a more routine element of institutional practice, the 'impacts' of patient engagement (PE) initiatives have proven…
Health care (4 works) · Knowledge management (4 works) · Political science (4 works) · Computer Science (3 works) · Health technology (3 works) · Medicine (3 works) · Mental Health and Patient Involvement (3 works) · Pharmaceutical industry and healthcare (3 works) · Psychology (3 works) · Public relations (3 works)